To view the full citation, click here.
Comparative Organ System Development: Continuing the Series
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
To view the full citation, click here.
Toxicology, 2003
There are currently no validated or widely accepted methods for evaluating the effects of a chemical on the developing immune system.
Journal of Allergy and Clinical Immunology, 2002
Immune-mediated drug hypersensitivity reactions (IDHR) have a significant impact on clinical practice, drug development, and public health.
Toxicologic Pathology, 2002
Methapyrilene (MP) exposure of animals can result in an array of adverse pathological responses including hepatotoxicity.
Human and Experimental Toxicology, 2002
Keliximab is a human-cynomolgus monkey chimeric (Primatized) monoclonal antibody with specificity for human and chimpanzee CD4.
Human and Experimental Toxicology, 2002
Identifying critical windows in immune system development is crucial for determination of either safety or vulnerability to exposure to specific agents during rapidly changing phases of ontogeny.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.